Co-Administration of Mavacamten and Tacrolimus in a Renal Transplant Recipient With Obstructive Hypertrophic Cardiomyopathy. (PubMed, JACC Case Rep) - Oct 10, 2026 - "Low-dose mavacamten and tacrolimus coadministration is feasible. However, rigorous tacrolimus therapeutic drug monitoring remains essential, especially during mavacamten dose escalation."
Journal • Cardiomyopathy • Cardiovascular • Genetic Disorders • Hypertrophic Cardiomyopathy • Obstructive Hypertrophic Cardiomyopathy • Transplantation • CYP3A4
|
|
Andrew Willeford; Arman Faravardeh; Jorge Silva Enciso; Quan M Bui
|